Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders

References

• Aubourg P, Wanders R. 2013. Peroxisomal disorders. Handb Clin Neurol. 113:1593–1609.
   PubMedGoogle Scholar
• Balazy M, Murphy RC. 1986. Determination of sulfidopeptide leukotrienes in biological fluids by gas chromatography/mass spectrometry. Anal Chem. 58:1098–1101.
   PubMed Web of Science ®Google Scholar
• Belmaker RH. 2004. Bipolar disorder. N Engl J Med. 351:476–486.
   PubMed Web of Science ®Google Scholar
• Bluml S, Philippart M, Schiffmann R, Seymour K, Ross BD. 2003. Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination. Neurology. 61:648–654.
   PubMed Web of Science ®Google Scholar
• Bluml S, Seymour KJ, Ross BD. 1999. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med. 4:643–654.
   Web of Science ®Google Scholar
• Boksa P. 2013. A way forward for research on biomarkers for psychiatric disorders. J Psychiatry Neurosci. 38:75–77.
   PubMed Web of Science ®Google Scholar
• Bradbury J. 2011. Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients. 3:529–554.
   PubMed Web of Science ®Google Scholar
• Buck A, Ly A, Balluff B, Sun N, Gorzolka K, Feuchtinger A, et al. 2015. High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples. J Pathol. 237:123–132.
   PubMed Web of Science ®Google Scholar
• Byrdwell WC. 1998. Dual parallel mass spectrometers for analysis of sphingolipid, glycerophospholipid and plasmalogen molecular species. Rapid Commun Mass Spectrom. 12:256–272.
   PubMed Web of Science ®Google Scholar
• Byrdwell WC. 2001. Atmospheric pressure chemical ionization mass spectrometry for analysis of lipids. Lipids. 36:327–346.
   PubMed Web of Science ®Google Scholar
• Byrdwell WC, Emken EA. 1995. Analysis of triglycerides using atmospheric pressure chemical ionization mass spectrometry. Lipids. 30:173–175.
   PubMed Web of Science ®Google Scholar
• Campbell S, MacQueen G. 2004. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci. 29:417–426.
   PubMed Web of Science ®Google Scholar
• Caughlin S, Hepburn JD, Park DH, Jurcic K, Yeung KK, Cechetto DF, et al. 2015. Increased expression of simple ganglioside species GM2 and GM3 detected by MALDI imaging mass spectrometry in a combined rat model of Aβ toxicity and stroke. PLoS One. 10:e0130364
   PubMed Web of Science ®Google Scholar
• Chen S, Hoene M, Li J, Li Y, Zhao X, Häring HU, et al. 2013. Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J Chromatogr a. 1298:9–16.
   PubMed Web of Science ®Google Scholar
• Cheon Y, Park JY, Modi HR, Kim HW, Lee HJ, Chang L, et al. 2011. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain. J Nerurochem. 119:364–376.
   PubMed Web of Science ®Google Scholar
• Chilton IIIFH., Murphy RC. 1986. Fast atom bombardment analysis of arachidonic acid-containing phosphatidylcholine molecular species. Biomed Environ Mass Spectrom. 13:71–76.
   PubMedGoogle Scholar
• Christie WW. 2003. Lipid analysis. Christie WW, editor. Bridgwater, England: The Oily Press.
   Google Scholar
• Conklin SM, Runyan CA, Leonard S, Reddy RD, Muldoon MF, Yao JK. 2010. Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. Prostaglandins Leukot Essent Fatty Acids. 82:111–119.
   PubMed Web of Science ®Google Scholar
• Cooper MJ, Anders MW. 1975. High pressure liquid chromatography of fatty acids and lipids. J Chromatogr Sci. 13:407–411.
   PubMed Web of Science ®Google Scholar
• Cortassa S, Caceres V, Bell LN, O’Rourke B, Paolocci N, Aon MA. 2015. From metabolomics to fluxomics: a computational procedure to translate metabolite profiles into metabolic fluxes. Biophys J. 108:163–172.
   PubMed Web of Science ®Google Scholar
• de Jong C, Kikkert HK, Seggers J, Boehm G, Decsi T, Hadders-Algra M. 2015. Neonatal fatty acid status and neurodevelopmental outcome at 9 years. Early Hum Dev. 91:587–591.
   PubMed Web of Science ®Google Scholar
• Demirkan A, Isaacs A, Ugocsai P, Liebisch G, Struchalin M, Rudan I, et al. 2013. Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study. J Psychiatr Res. 47:357–362.
   PubMed Web of Science ®Google Scholar
• Díaz M, Fabelo N, Martín V, Ferrer I, Gómez T, Marín R. 2015. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer’s disease. J Alzheimers Dis. 43:1185–1198.
   PubMed Web of Science ®Google Scholar
• Duffin KL, Henion JD, Shieh JJ. 1991. Electrospray and tandem mass spectrometric characterization of acylglycerol mixtures that are dissolved in nonpolar solvents. Anal Chem. 63:1781–1788.
   PubMed Web of Science ®Google Scholar
• Emmett MR, Kroes RA, Moskal JR, Conrad CA, Priebe W, Laezza F, et al. 2014. Integrative biological analysis for neuropsychopharmacology. Neuropsychopharmacology. 39:5–23.
   PubMed Web of Science ®Google Scholar
• Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH, Jr. Murphy RC, Raetz CR, et al. 2005. A comprehensive classification system for lipids. J Lipid Res. 46:839–862.
   PubMed Web of Science ®Google Scholar
• Faria R, Santana MM, Aveleira CA, Simões C, Maciel E, Melo T, et al. 2014. Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress. Neuroscience. 273:1–11.
   PubMed Web of Science ®Google Scholar
• Feldberg W. 1976. Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis. Psychol Med. 6:359–369.
   PubMed Web of Science ®Google Scholar
• Fonteh AN, Harrington RJ, Harrington MG. 2004. Use of liquid chromatography and tandem mass spectrometry to measure metabolites in human cerebrospinal fluids. Neuroscience. 695:2004.
   Google Scholar
• Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, Harrington MG. 2006. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers. 22:39–64.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, et al. 2006. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 67:1954–1967.
   PubMed Web of Science ®Google Scholar
• Frey BN, Stanley JA, Nicoletti MA, Hatch JP, Soares LC. 2008. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord. 10:849.
   PubMed Web of Science ®Google Scholar
• Fuchs B, Schiller J, Süss R, Zscharnack M, Bader A, Müller P, et al. 2008. Analysis of stem cell lipids by offline HPTLC-MALDI-TOF MS. Anal Bioanal Chem. 392:849–860.
   PubMed Web of Science ®Google Scholar
• Garcia AD, Chavez JL, Mechref Y. 2014. Rapid and sensitive LC-ESI-MS of gangliosides. J Chromatogr B Analyt Technol Biomed Life Sci. 947948:1–7.
   Web of Science ®Google Scholar
• Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P, et al. 2007. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 31:1393–1396.
   PubMed Web of Science ®Google Scholar
• Gross RW. 1984. High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization. Biochemistry. 23:158–165.
   PubMed Web of Science ®Google Scholar
• Guo X, Lankmayr E. 2010. Multidimensional approaches in LC and MS for phospholipid bioanalysis. Bioanalysis. 2:1109–1123.
   PubMed Web of Science ®Google Scholar
• Hadley JS, Fradin A, Murphy RC. 1988. Electron capture negative ion chemical ionization analysis of arachidonic acid. Biomed Environ Mass Spectrom. 15:175–178.
   PubMedGoogle Scholar
• Hamazaki K, Choi KH, Kim HY. 2010. Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species. J Psychiatr Res. 44:688–693.
   PubMed Web of Science ®Google Scholar
• Han X, Gross RW. 2003. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res. 44:1071–1079.
   PubMed Web of Science ®Google Scholar
• Han X, Gross RW. 2005. Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev. 24:367–412.
   PubMed Web of Science ®Google Scholar
• Han L, Kitova EN, Li J, Nikjah S, Lin H, Pluvinage B, et al. 2015. Protein-glycolipid interactions studied in vitro using ESI-MS and nanodiscs: insights into the mechanisms and energetics of binding. Anal Chem. 87:4888–4896.
   PubMed Web of Science ®Google Scholar
• Henriksene K, O’Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, et al. 2014. The future of blood-based biomarkers for Alzheimer’s disease. Alzheimers Dement. 10:115–131.
   PubMed Web of Science ®Google Scholar
• Hermansson M, Käkelä R, Berghäll M, Lehesjoki AE, Somerharju P, Lahtinen U. 2005. Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study. J Neurochem. 95:609–617.
   PubMed Web of Science ®Google Scholar
• Horrobin DF. 1977. Schizophrenia as a prostaglandin deficiency disease. Lancet. 1:936–937.
   PubMed Web of Science ®Google Scholar
• Houjou T, Yamatani K, Imagawa M, Shimizu T, Taguchi R. 2005. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 19:654–666.
   PubMed Web of Science ®Google Scholar
• Howells FM, Ives-Deliperi VL, Horn NR, Stein DJ. 2013. Increased thalamic phospholipid concentration evident in bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry. 41:1–5.
   PubMed Web of Science ®Google Scholar
• Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G. 2009. Analytical strategies in lipidomics and applications in disease biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci. 877:2836–2846.
   PubMed Web of Science ®Google Scholar
• Huang TL, Chen JF. 2009. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation/immunity. Adv Clin Chem. 39:81–105.
   Web of Science ®Google Scholar
• Huang TL, Lin CC. 2015. Advances in biomarkers of major depressive disorder. Adv Clin Chem. 68:177–204.
   PubMedGoogle Scholar
• Hussain J, Liu Y, Lopes WA, Druzian JI, Souza CO, Carvalho CC, et al. 2015. Effects of different biomass drying and lipid extraction methods on algal lipid yield, fatty acid profile, and biodiesel quality. Appl Biochem Biotechnol. 175:3048–3057.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Bluml S, Leaf A, Ross BD. 2003. In vivo characterization of fatty acids in human adipose tissue using natural abundance 1H decoupled 13C MRS at 1.5 T: clinical applications to dietary therapy. NMR Biomed. 16:160–167.
   PubMed Web of Science ®Google Scholar
• Ivanova PT, Milne SB, Forrester JS, Brown HA. 2004. LIPID Arrays: New Tools in the Understanding of Membrane Dynamics and Lipid Signaling. Mol Interv. 4:86–96.
   PubMed Web of Science ®Google Scholar
• Jenkins BG, Koroshetz WJ, Beal F, Rosen BR. 1993. Evidence for impairment of energy metabolism in vivo in Huntington’s disease using localized 1H NMR spectroscopy. Neurology. 43:2689–2695.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, McEvoy J, Baillie R, Zhu H, Yao JK, Nimgaonkar VL, et al. 2012. Impaired plasmalogens in patients with schizophrenia. Psychiatry Res. 198:347–352.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, et al. 2007. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 12:934–945.
   PubMed Web of Science ®Google Scholar
• Kang YP, Lee WJ, Hong JY, Lee SB, Park JH, Kim D, et al. 2014. Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients. J Proteome Res. 13:3919–3929.
   PubMed Web of Science ®Google Scholar
• Katajamaa M, Miettinen J, Oresic M. 2006. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics. 22:634–636.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Merikangas KR, Wang PS. 2007. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 3:137–158.
   PubMed Web of Science ®Google Scholar
• Kim HW, Rapoport SI, Rao JS. 2011. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol Psychiatry. 16:419–428.
   PubMed Web of Science ®Google Scholar
• Kim HYJr., Salem N. 1990. Separation of lipid classes by solid phase extraction. J Lipid Res. 31:2285–2289.
   PubMed Web of Science ®Google Scholar
• Kim JM, Stewart R, Kang HJ, Jeong BO, Kim SY, Bae KY, et al. 2014. Longitudinal associations between serum cholesterol levels and suicidal ideation in an older Korean population. J Affect Disord. 152154:517–521.
   Web of Science ®Google Scholar
• Kliman M, May JC, McLean JA. 2011. Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry. Biochim Biophys Acta-Mol Cell Biol Lip. 1811:935–945.
   PubMed Web of Science ®Google Scholar
• Kluge W, Alsaif M, Guest PC, Schwarz E, Bahn S. 2011. Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders. Expert Rev Mol Diagn. 11:721–733.
   PubMed Web of Science ®Google Scholar
• Knittelfelder OL, Weberhofer BP, Eichmann TO, Kohlwein SD, Rechberger GN. 2014. A versatile ultra-high performance LC-MS method for lipid profiling. J Chromatogr B Analyt Technol Biomed Life Sci. 951952:119–128.
   Web of Science ®Google Scholar
• Kopf T, Schaefer HL, Troetzmueller M, Koefeler H, Broenstrup M, Konovalova T, et al. 2014. Influence of fenofibrate treatment on triacylglycerides, diacylglycerides and fatty acids in fructose fed rats. PLoS One. 9:e106849.
   PubMed Web of Science ®Google Scholar
• Laboureur L, Ollero M, Touboul D. 2015. Lipidomics by supercritical fluid chromatography. Int J Mol Sci. 16:13868–13884.
   PubMed Web of Science ®Google Scholar
• Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, et al. 2009. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry. 14:269–279.
   PubMed Web of Science ®Google Scholar
• Le-Niculescu H, Kurian SM, Yehyawi N, Dike S, Patel SD, Edenberg HJ, et al. 2009. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry. 14:156–174.
   PubMed Web of Science ®Google Scholar
• Lísa M, Holcapek M. 2015. High-throughput and comprehensive lipidomic analysis using ultrahigh-performance supercritical fluid chromatography-mass spectrometry. Anal Chem. 87:7187–7195.
   PubMed Web of Science ®Google Scholar
• Liu JJ, Galfalvy HC, Cooper TB, Oquendo MA, Grunebaum MF, Mann JJ, et al. 2013. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. J Clin Psychiatry. 74:732–738.
   PubMed Web of Science ®Google Scholar
• Liu S, Sjövall J, Griffiths WJ. 2003. Neurosteroids in rat brain: extraction, isolation, and analysis by nanoscale liquid chromatography-electrospray mass spectrometry. Anal Chem. 75:5835–5846.
   PubMed Web of Science ®Google Scholar
• Liu X, Zheng P, Zhao X, Zhang Y, Hu C, Li J, et al. 2015. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res. 14:2322–2330.
   PubMed Web of Science ®Google Scholar
• Löfgren L, Ståhlman M, Forsberg GB, Saarinen S, Nilsson R, Hansson GI. 2012. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J Lipid Res. 53:1690–1700.
   PubMed Web of Science ®Google Scholar
• Malhotra N, Grover S, Chakrabarti S, Kulhara P. 2013. Metabolic syndrome in schizophrenia. Indian J Psychol Med. 35:227–240.
   PubMedGoogle Scholar
• Martins-de-Souza D. 2014. Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder. Dialogues Clin Neurosci. 16:63–73.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Hayashi A. 1991. FAB/mass spectrometry of lipids. Prog Lipid Res. 30:301–322.
   PubMed Web of Science ®Google Scholar
• McEvoy J, Baillie RA, Zhu H, Buckley P, Keshavan MS, Nasrallah HA, et al. 2013. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PLoS One. 8:e68717.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, et al. 2007. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry. 62:17–24.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pandey GN. 2010. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 126:303–311.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Jandacek R, Tso P, Dwivedi Y, Ren X, Pandey GN. 2013. Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease. J Psychiatr Res. 47:1187–1191.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Liu Y. 2011. Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. J Affect Disord. 129:359–363.
   PubMed Web of Science ®Google Scholar
• Meikle P, Barlow C, Weir J. 2009. Lipidomics and lipid biomarker discovery. Aus Biochemist. 40:12–16.
   Google Scholar
• Metz TO, Zhang Q, Page JS, Shen Y, Callister SJ, Jacobs JM, et al. 2007. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med. 1:159–185.
   PubMed Web of Science ®Google Scholar
• Meyer BJ, Grenyer BF, Crowe T, Owen AJ, Grigonis-Deane EM, Howe PR. 2013. Improvement of major depression is associated with increased erythrocyte DHA. Lipids. 48:863–868.
   PubMed Web of Science ®Google Scholar
• Meyerhoff DJ, Mackay S, Constans JM, Norman D, Van Dyke C, Fein G, et al. 1994. Axonal injury and membrane alterations in Alzheimer’s disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol. 36:40–47.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Vaze A, Rao S. 2009. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 374:609–619.
   PubMed Web of Science ®Google Scholar
• Moghaddam B, Javitt D. 2012. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 37:4–15.
   PubMed Web of Science ®Google Scholar
• Monkul ES, Yildiz AC, Soares J. 2004. [Magnetic resonance spectroscopy (MRS) applications in bipolar disorder]. Turk Psikiyatri Derg. 15:138–147.
   PubMedGoogle Scholar
• Naudí A, Cabré R, Jové M, Ayala V, Gonzalo H, Portero-Otín M, et al. 2015. Lipidomics of human brain aging and Alzheimer's disease pathology. Int Rev Neurobiol. 122:133–189.
   PubMed Web of Science ®Google Scholar
• Niemoller TD, Bazan NG. 2010. Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat. 91:85–89.
   PubMed Web of Science ®Google Scholar
• Nygren H, Seppänen-Laakso T, Castillo S, Hyötyläinen T, Orešič M. 2011. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol. 708:247–257.
   PubMedGoogle Scholar
• Ogawa S, Tomaru K, Matsumoto N, Watanabe S, Higashi T. 2015. LC/ESI-MS/MS method for determination of salivary eicosapentaenoic acid concentration to arachidonic acid concentration ratio. Biomed Chromatogr. doi: 10.1002/bmc.3421.
   Web of Science ®Google Scholar
• Ongur D, Drevets WC, Price JL. 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA. 95:13290–13295.
   PubMed Web of Science ®Google Scholar
• Orešič M, Seppänen-Laakso T, Sun D, Tang J, Therman S, Viehman R, et al. 2012. Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 4:1.
   Web of Science ®Google Scholar
• Orešič M, Tang J, Seppänen-Laakso T, Mattila I, Saarni SE, Saarni SI, et al. 2011. Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med. 3:19
   PubMed Web of Science ®Google Scholar
• Paglia G, Kliman M, Claude E, Geromanos S, Astarita G. 2015. Applications of ion-mobility mass spectrometry for lipid analysis. Anal Bioanal Chem. 407:4995–5007.
   PubMed Web of Science ®Google Scholar
• Pariante CM, Lightman SL. 2008. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 31:464–468.
   PubMed Web of Science ®Google Scholar
• Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. 1999. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 175:259–262.
   PubMed Web of Science ®Google Scholar
• Perälä J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, et al. 2007. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 64:19–28.
   PubMed Web of Science ®Google Scholar
• Pizarro C, Arenzana-Rámila I, Pérez-del-Notario N, Pérez-Matute P, González-Sáiz JM. 2013. Plasma lipidomic profiling method based on ultrasound extraction and liquid chromatography mass spectrometry. Anal Chem. 85:12085–12092.
   PubMed Web of Science ®Google Scholar
• Ponizovsky AM, Modai I, Nechamkin Y, Barshtein G, Ritsner MS, Yedgar S, et al. 2001. Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology. Schizophr Res. 52:121–126.
   PubMed Web of Science ®Google Scholar
• Pulfer MK, Harrison K, Murphy RC. 2004. Direct electrospray tandem mass spectrometry of the unstable hydroperoxy bishemiacetal product derived from cholesterol ozonolysis. J Am Soc Mass Spectrom. 15:194–202.
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, Kim HW. 2010. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 15:384–392.
   PubMed Web of Science ®Google Scholar
• Rao JS, Lee HJ, Rapoport SI, Bazinet RP. 2008. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry. 13:585–596.
   PubMed Web of Science ®Google Scholar
• Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. 2012. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord. 136:63–71.
   PubMed Web of Science ®Google Scholar
• Rapoport SI, Basselin M, Kim HW, Rao JS. 2009. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 61:185–209.
   PubMedGoogle Scholar
• Reese EA, Cheon Y, Ramadan E, Kim HW, Chang L, Rao JS, et al. 2012. Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder. Prostaglandins Leukot Essent Fatty Acids. 87:71–77.
   PubMed Web of Science ®Google Scholar
• Robins SJ, Patton GM. 1986. Separation of phospholipid molecular species by high performance liquid chromatography: potentials for use in metabolic studies. J Lipid Res. 27:131–139.
   PubMed Web of Science ®Google Scholar
• Robinson EM, Jia M, Trumble SJ, Usenko S. 2015. Selective pressurized liquid extraction technique for halogenated organic pollutants in marine mammal blubber: a lipid-rich matrix. J Chromatogr A. 1385:111–115.
   PubMed Web of Science ®Google Scholar
• Ruiz-Gutiérrez V, Pérez-Camino MC. 2000. Update on solid-phase extraction for the analysis of lipid classes and related compounds. J Chromatogr A. 885:321–341.
   PubMed Web of Science ®Google Scholar
• Sarri KO, Linardakis M, Tzanakis N, Kafatos AG. 2008. Adipose DHA inversely associated with depression as measured by the Beck Depression Inventory. Prostaglandins Leukot Essent Fatty Acids. 78:117–122.
   PubMed Web of Science ®Google Scholar
• Sarris J, Mischoulon D, Schweitzer I. 2012. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 73:81–86.
   PubMed Web of Science ®Google Scholar
• Saunders EF, Reider A, Singh G, Gelenberg AJ, Rapoport SI. 2015. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment. Bipolar Disord. 17:729-742.
   Web of Science ®Google Scholar
• Schött HF, Lütjohann D. 2015. Validation of an isotope dilution gas chromatography-mass spectrometry method for combined analysis of oxysterols and oxyphytosterols in serum samples. Steroids. 99:139–150.
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Shelton RC, Duman RS. 2011. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology. 36:2375–2394.
   PubMed Web of Science ®Google Scholar
• Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G, et al. 2004. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry. 56:41–45.
   PubMed Web of Science ®Google Scholar
• Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, et al. 2003. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol. 71:3–29.
   PubMed Web of Science ®Google Scholar
• Schwab U, Seppänen-Laakso T, Yetukuri L, Agren J, Kolehmainen M, Laaksonen DE, et al. 2008. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-the GENOBIN study. PLoS One. 3:e2630.
   PubMed Web of Science ®Google Scholar
• Schwarz E, Bahn S. 2008. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Br J Pharmacol. 153:S133–S136.
   PubMed Web of Science ®Google Scholar
• Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, et al. 2008. High throughput lipidomic profiling of schizophrenia and bipolar disor der brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and Ceramides. J Proteome Res. 7:4266–4277.
   PubMed Web of Science ®Google Scholar
• Senaratne R, Milne AM, MacQueen GM, Hall GB. 2009. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res. 172:205–209.
   PubMed Web of Science ®Google Scholar
• Sethi S, Brietzke E. 2015. Omics-based biomarkers: Application of metabolomics in neuropsychiatric disorders. Int J Neuropsychopharmacol. doi: 10.1093/ijnp/pyv096.
   Web of Science ®Google Scholar
• Sethi S, Chourasia D, Parhar IS. 2015. Approaches for targeted proteomics and its potential applications in neuroscience. J Biosci. 40:607–627.
   PubMed Web of Science ®Google Scholar
• Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. 1996. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 93:3908–3913.
   PubMed Web of Science ®Google Scholar
• Shimshoni JA, Basselin M, Li LO, Coleman RA, Rapoport SI, Modi HR. 2011. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate’s efficacy against bipolar disorder. Biochim Biophys Acta. 1811:163–169.
   PubMed Web of Science ®Google Scholar
• Skosnik PD, Yao JK. 2003. From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia? Prostaglandins Leukot Essent Fatty Acids. 69:367–384.
   PubMed Web of Science ®Google Scholar
• Smith DF, Kilgour DP, Konijnenburg M, O'Connor PB, Heeren RM. 2013. Absorption mode FTICR mass spectrometry imaging. Anal Chem. 85:11180–11184.
   PubMed Web of Science ®Google Scholar
• Sommerer D, Süss R, Hammerschmidt S, Wirtz H, Arnold K, Schiller J. 2004. Analysis of the phospholipid composition of bronchoalveolar lavage (BAL) fluid from man and minipig by MALDI-TOF mass spectrometry in combination with TLC. J Pharm BioMed Anal. 35:199–206.
   PubMed Web of Science ®Google Scholar
• Sonnino S, Aureli M, Grassi S, Mauri L, Prioni S, Prinetti A. 2014. Lipid rafts in neurodegeneration and neuroprotection. Mol Neurobiol. 50:130–148.
   PubMed Web of Science ®Google Scholar
• Spener F, Lagarde M, Geloen A, Record M. 2003. What is lipidomics? Eur J Lipid Sci Technol. 105:481–482.
   Web of Science ®Google Scholar
• Ståhlman M, Ejsing CS, Tarasov K, Perman J, Borén J, Ekroos K. 2009. High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 877:2664–2672.
   PubMed Web of Science ®Google Scholar
• Sublette ME, Ellis SP, Geant AL, Mann JJ. 2011. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 72:1577–1584.
   PubMed Web of Science ®Google Scholar
• Sun H, Zhang A, Yan G, Piao C, Li W, Sun C, et al. 2013. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics. 12:710–719.
   PubMed Web of Science ®Google Scholar
• Sun S, Yang S, Mao Y, Jia X, Zhang Z. 2015. Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor. Lipids Health Dis. 14:22.
   PubMed Web of Science ®Google Scholar
• Taha AY, Cheon Y, Ma K, Rapoport SI, Rao JS. 2013. Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J Psychiatr Res. 47:636–643.
   PubMed Web of Science ®Google Scholar
• Taguchi R, Hayakawa J, Takeuchi Y, Ishida M. 2000. Two dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. J Mass Spectrom. 35:953–966.
   PubMed Web of Science ®Google Scholar
• Tian H, Bai J, An Z, Chen Y, Zhang R, He J, et al. 2013. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 27:2071–2080.
   PubMed Web of Science ®Google Scholar
• Vilella F, Ramirez LB, Simón C. 2013. Lipidomics as an emerging tool to predict endometrial receptivity. Fertil Steril. 99:1100–1106.
   PubMed Web of Science ®Google Scholar
• Wallner B, Machatschke IH. 2009. The evolution of violence in men: the function of central cholesterol and serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 33:391–397.
   PubMed Web of Science ®Google Scholar
• Weerasinghe GR, Rapoport SI, Bosetti F. 2004. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res Bull. 63:485–489.
   PubMed Web of Science ®Google Scholar
• Weintraub ST, Pinckard RN, Hail M. 1991. Electrospray ionization for analysis of platelet-activating factor. Rapid Commun Mass Spectrom. 5:309–311.
   PubMed Web of Science ®Google Scholar
• Wood PL. 2012. Lipidomics of Alzheimer's disease: current status. Alzheimers Res Ther. 4:5.
   PubMed Web of Science ®Google Scholar
• Wood PL. 2014. Accumulation of N-acylphosphatidylserines and N-acylserines in the frontal cortex in schizophrenia. Neurotransmitter. 1:e263
   PubMedGoogle Scholar
• Wood PL, Filiou MD, Otte DM, Zimmer A, Turck CW. 2014. Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72/G30 transgenic mouse. Schizophr Res. 159:365–369.
   PubMed Web of Science ®Google Scholar
• Wood PL, Holderman NR. 2015. Dysfunctional glycosynapses in schizophrenia: Disease and regional specificity. Schizophr Res. 166:235–237.
   PubMed Web of Science ®Google Scholar
• Wood PL, Unfried G, Whitehead W, Phillipps A, Wood JA. 2015. Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia. Schizophr Res. 161:506–510.
   PubMed Web of Science ®Google Scholar
• Wrona M, Mauriala T, Bateman KP, Mortishire-Smith RJ, O’Connor D. 2005. ‘All-in-One’ analysis for metabolite identification using liquid chromatography/hybrid quadru pole time-of-flight mass spectrometry with collision energy switching. Rapid Commun Mass Spectrom. 19:2597–2602.
   PubMed Web of Science ®Google Scholar
• Yang Q, Shi X, Gu Q, Zhao S, Shan Y, Xu G. 2012. On-line two dimensional liquid chromatography/mass spectrometry for the analysis of triacylglycerides in peanut oil and mouse tissue. J Chromatogr B Analyt Technol Biomed Life Sci. 895/896:48–55.
   Web of Science ®Google Scholar
• Yao JK, Leonard S, Reddy RD. 2000. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res. 42:7–17.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Zhao YY, Cheng XL, Lin RC, Dai Z, Zhou C. 2013. Metabonomic study of biochemical changes in the rat urine induced by Pinellia ternata (Thunb.) Berit. J Pharm Biomed Anal. 85:186–193.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Lin RC. 2014. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry. Int Rev Cell Mol Biol. 313:1–26.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Lin RC, Wei F. 2015. Lipidomics applications for disease biomarker discovery in mammal models. Biomark Med. 9:153–168.
   PubMed Web of Science ®Google Scholar
• Zietkowski D, Payne GS, Nagy E, Mobberley MA, Ryder TA, deSouza NM. 2012. Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines. Magn Reson Med. 68:369–377.
   PubMed Web of Science ®Google Scholar